Authors' reply
- PMID: 32382242
- PMCID: PMC7196615
- DOI: 10.20524/aog.2020.0472
Authors' reply
Conflict of interest statement
Conflict of Interest: None
References
-
- Chen Q, Long X, Ji Y, et al. Randomised controlled trial:susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment. Aliment Pharmacol Ther. 2019;49:1385–1394. - PubMed
-
- Liou JM, Chen PY, Luo JC, et al. Taiwan Gastrointestinal Disease and Helicobacter Consortium. Efficacies of genotypic resistance- guided vs empirical therapy for refractory Helicobacter pylori infection. Gastroenterology. 2018;155:1109–1119. - PubMed
LinkOut - more resources
Full Text Sources